Tag Archives: Pharma

Photo by John Moore/Getty Images

Big Pharma’s Tobacco Moment as Star Lawyers Push Opioid Suits

Big Pharma’s Tobacco Moment as Star Lawyers Push Opioid Suits

By Jef Feeley and Jared S. Hopkins, Bloomberg News Big Pharma is having a Big Tobacco moment as litigation over opioids attract star lawyers and a growing list of states and local governments seeking their own multibillion- dollar payout to deal with costs of a burgeoning drug epidemic. On Tuesday, South Carolina became the sixth

Photographer: Kiyoshi Ota/Bloomberg

Biotech M&A Falls Off as Trump Dashes Hopes of a New Pharma Boom

By Jared S Hopkins, Bloomberg News After almost three years of booming health-care dealmaking in the U.S., 2017 is off to a slow start. Pharmaceutical and biotech acquisitions totaled $44 billion last quarter, down 13 percent from a year earlier, and 35 percent below the first quarter of 2015, according to data compiled by Bloomberg.

Martin Shkreli. Photo by Paul Taggart (Bloomberg)

Shkreli’s Former Company Names New GC

Retrophin Inc., the biopharmaceutical company locked in litigation with its embattled founder Martin Shkreli, announced earlier this week it has appointed Elizabeth Reed as its general counsel and corporate secretary. Reed joins from Celladon Corporation, where she was general counsel and secretary, and which merged in 2016 with Eiger BioPharmaceuticals, Inc. Retrophin has been in the headlines

The headquarters of Teva Pharmaceutical Industries Ltd., sit in Petah Tikva, Israel, on Wednesday, June 17, 2009. Teva Pharmaceutical Industries Ltd., which bought Barr Laboratories Inc. for $7.4 billion last year, is ready for another "major" acquisition and may look beyond generic drugs for the purchase, Yanai said. Photographer: Ahikam Seri/Bloomberg News

Teva to Pay $519 Million in U.S. Probe Over Foreign Bribes

By Tom Schoenberg and David McLaughlin, Bloomberg News Teva Pharmaceutical Industries Ltd. agreed to pay $519 million to U.S. authorities after admitting to paying bribes in Russia, Ukraine and Mexico to boost sales. Teva, the world’s biggest maker of generic medicines, admitted to making corrupt payments to public officials and doctors, including an unidentified high-ranking Russian

Astra Zeneca

Are More ‘Purple Pill’ Lawsuits Around the Corner?

By Julie A. Steinberg, Bloomberg BNA AstraZeneca’s “purple pill” Nexium caused an Illinois man’s kidney disease, according to the latest suit in what could be a new wave of litigation. The plaintiff George Mullen sued last week in federal court in Brooklyn and accused AstraZeneca Pharmaceuticals LP and AstraZeneca LP of failing to warn that Nexium, a proton pump inhibitor